CHARAH SOLUTIONS, INC.
December 8, 2022
WE ARE NOT ASKING YOU FOR A PROXY AND
YOU ARE REQUESTED NOT TO SEND US A PROXY
We are furnishing this Information Statement to the stockholders of
record of Charah Solutions, Inc. (together with its
subsidiaries, the “Company,” “we,” “us” or “our”) in connection
with a written consent in lieu of a special meeting, dated
November 23, 2022, executed and delivered to the Company by
the holders of approximately 72.43% of the voting power of our
outstanding voting stock, outstanding as of the date of such
consent.
The written consent was effected in accordance with the Delaware
General Corporation Law (the “DGCL”), our Amended and Restated
Certificate of Incorporation, as amended (our “certificate of
incorporation”) and our Amended and Restated Bylaws, as amended
(our “bylaws”), which permit any action which may be taken at a
meeting of our stockholders to also be taken by written consent of
our stockholders holding outstanding stock having at least the
number of votes necessary to approve such action at a meeting at
which all shares entitled to vote thereon were present and voted.
The action taken by written consent of our stockholders dated on
November 23, 2022 required the approval of the holders of a
majority of our outstanding shares of (i) common stock, par
value $0.01 per share (the “common stock”), voting as a
single class on an as-converted basis, (ii) Series A Preferred
Stock, par value $0.01 per share (the “Series A Preferred Stock”),
voting as a separate class, and (iii) Series B Preferred
Stock, par value $0.01 per share (the “Series B Preferred Stock”
and, together with the Series A Preferred Stock, the “preferred
stock,” and the preferred stock, together with the common stock,
the “voting stock”), voting as a separate class.
This Information Statement will be mailed on or about
December 8, 2022 to holders of our outstanding common stock of
record as of the close of business on November 23, 2022, which
we refer to as the “record date” for mailing. On that date, there
were 33,795,850 shares of our common stock, 26,000 shares of Series
A Preferred Stock and 30,000 shares of Series B Preferred Stock
issued and outstanding. Pursuant to Rule 14c-2 of the Securities
Exchange Act of 1934, as amended (the “Exchange Act”), the action
will become effective on or after December 28, 2022 which is
20 calendar days following the date on which we first mail this
Information Statement to our stockholders.
On November 14, 2022, our board of directors, acting by
unanimous written consent, approved, and recommended that our
stockholders approve, a proposal to approve and adopt the amendment
to our certificate of incorporation (the “Certificate of
Amendment”), the form of which is attached as Annex A to this Information
Statement and incorporated herein by reference, to effect a reverse
stock split of our issued and outstanding common stock by a ratio
of one new share for every ten shares of common stock (the “Reverse
Stock Split”).
Holders of a majority of our outstanding voting stock acting by
written consent in lieu of a special meeting on November 23,
2022 approved and adopted the Certificate of Amendment to effect
the Reverse Stock Split, at any time before February 1, 2023,
in the sole discretion of the board of directors without further
approval or authorization of the Company’s stockholders.
This Information Statement contains a summary of the material
aspects of the actions relating to the Reverse Stock Split approved
by the board of directors and the holders of a majority of our
outstanding voting stock.